SCHEMBL3249507

SCHEMBL3249507

O=C(O)c1c[nH]c2c(=O)[nH]c3ccc(-c4csc(Nc5ccc(Cl)c(Cl)c5)n4)cc3c12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A2 P19784 2/20 0.48
CSNK2B P67870 2/20 0.48
ALOX5 P09917 1/20 0.48
VCP P55072 1/20 0.48
CSNK2A1 P68400 4/20 0.44
CSNK2A3 Q8NEV1 1/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
MAPT P10636 2/20 0.43
LMNA P02545 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
PRMT5 O14744 2/20 0.43
WDR77 Q9BQA1 2/20 0.43
HPGDS O60760 1/20 0.43
SIRT5 Q9NXA8 1/20 0.42
ABL1 P00519 2/20 0.42
CFTR P13569 2/20 0.42
BLM P54132 2/20 0.41
KDM4E B2RXH2 1/20 0.40
POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3244502 0.89 CSNK2A1 (0.49) CSNK2A2CSNK2BALOX5VCPCSNK2A1
SCHEMBL3249037 0.88 ALOX5 (0.43) CSNK2A2CSNK2BALOX5VCPMEN1
SCHEMBL3253478 0.88 CSNK2A2 (0.41) CSNK2A2CSNK2BALOX5CSNK2A1CSNK2A3
SCHEMBL3249096 0.86 RAB9A (0.45) CSNK2A2CSNK2BALOX5CSNK2A1CSNK2A3
SCHEMBL4167032 0.86 ALOX5 (0.44) CSNK2A2CSNK2BALOX5VCPCSNK2A1
SCHEMBL3241800 0.82 RAB9A (0.41) CSNK2A2CSNK2BCSNK2A1CSNK2A3MEN1
SCHEMBL3252671 0.82 ALOX5 (0.42) ALOX5VCPMEN1KMT2AMAPT
SCHEMBL13950891 0.81 ALOX5 (0.42) ALOX5VCPMEN1KMT2AMAPT
Propionic Acid SCHEMBL4167038 0.81 ALOX5 (0.47) CSNK2A2CSNK2BALOX5VCPCSNK2A1
SCHEMBL3244365 0.80 ABL1 (0.51) MEN1KMT2AMAPTLMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1899335-B1 PYRROLOQUINOLINE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS PF MEDICAMENT (FR) 2010-05-19 EP claimed
EP-1899335-A1 PYRROLOQUINOLINE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS PIERRE FABRE MEDICAMENT (FR) 2008-03-19 EP claimed
WO-2007003611-A1 PYRROLOQUINOLINE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS PIERRE FABRE MEDICAMENT (FR) 2007-01-11 WO claimed
EP-1899335-B1 PYRROLOQUINOLINE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS PF MEDICAMENT (FR) 2010-05-19 EP disclosed
EP-1899335-A1 PYRROLOQUINOLINE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS PIERRE FABRE MEDICAMENT (FR) 2008-03-19 EP disclosed
WO-2007003611-A1 PYRROLOQUINOLINE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS PIERRE FABRE MEDICAMENT (FR) 2007-01-11 WO disclosed